About Orbus

Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies.

We at Orbus are committed to bringing innovative products to the extremely under served patients affected by rare diseases.  We are focused and passionate about bringing a more positive outcome to patients facing life threatening or significantly life altering diseases.

Currently Orbus Therapeutics is working to develop and commercialize eflornithine in North America.


Our team is committed to improving the health and quality of life for patients with rare diseases. 


Orbus Therapeutics is developing products for patients fighting   diseases that affect only a small percentage of the population.


Our Phase 3  clinical trial is currently enrolling patients with recurrent anaplastic astrocytoma.